Prosecution Insights
Last updated: October 02, 2026

Examiner: BREDEFELD, RACHAEL EVA

Tech Center 3700 • Art Units: 1611 3786

This examiner grants 27% of resolved cases

Analysis

Rachael Eva Bredefeld is an examiner in Tech Center 3700 and Art Unit 1611. The examiner has 526 resolved cases and an allowance rate of 27.4 percent. This rate suggests an examination environment where many applications do not reach allowance. The median days to allowance for successful cases is 1660.

The interview lift is 35.0 percent. This figure indicates that conducting an interview is associated with a higher likelihood of allowance compared to the 27.4 percent base rate. Practitioners should consider this lift as a primary method for advancing prosecution in Art Unit 1611.

The 526 resolved cases provide a substantial basis for understanding the 1660 day timeline. The allowance rate reflects the examiner's historical approach to applications. By utilizing the 35.0 percent lift, applicants may improve their outcomes in Tech Center 3700. This profile provides a data-grounded view of the prosecution environment.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

27.4%
Allow Rate
-42.6% vs TC avg
538
Total Applications
+35.0%
Interview Lift
1660
Avg Prosecution Days
Based on 526 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
13.2%
§102 Novelty
42.7%
§103 Obviousness
25.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18873493 USE OF UV FILTERS FOR THE TREATMENT OF ACNE Non-Final OA DSM IP ASSETS B.V.
18687962 METHODS AND COMPISITIONS FOR AMELIORATING BIOMARKERS ASSOCIATED WITH CARDIOVASCUALR RISK USING (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE Final Rejection AXSOME THERAPEUTICS, INC.
18537432 SOLID DISPERSIONS COMPRISING AMORPHOUS PIMOBENDAN AND ONE OR MORE STABILIZING POLYMERS Non-Final OA Boehringer Ingelheim Vetmedica GmbH
18487841 ESTER ANALOGS OF PSILOCIN, PROCESSES FOR THE PREPARATION THEREOF, AND METHODS OF USE Final Rejection Invyxis, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month